How melanoma is treated in real life

被引:5
作者
Dummer, Reinhard [1 ]
Schadendorf, Dirk [1 ]
机构
[1] Univ Zurich Hosp, Dermatol Klin, CH-8091 Zurich, Switzerland
关键词
D O I
10.1001/archderm.144.5.664
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
引用
收藏
页码:664 / 665
页数:2
相关论文
共 14 条
[1]
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma [J].
Balch, CM ;
Buzaid, AC ;
Soong, SJ ;
Atkins, MB ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3635-3648
[2]
Randomized dose-escalation study evaluating peginterferon alfa-2a in patients with metastatic malignant melanoma [J].
Dummer, R ;
Garbe, C ;
Thompson, JA ;
Eggermont, AM ;
Yoo, K ;
Maier, T ;
Bergstrom, B .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) :1188-1194
[3]
Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma [J].
Dummer, R ;
Panizzon, R ;
Bloch, PH ;
Burg, G .
DERMATOLOGY, 2005, 210 (01) :39-44
[4]
Eggermont AM, 2007, J CLIN ONCOL, V25
[5]
Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial [J].
Eggermont, AMM ;
Suciu, S ;
MacKie, R ;
Ruka, W ;
Testori, A ;
Kruit, W ;
Punt, CJA ;
Delauney, M ;
Sales, F ;
Groenewegen, G ;
Ruiter, DJ ;
Jagiello, I ;
Stoitchkov, K ;
Keilholz, U ;
Lienard, D .
LANCET, 2005, 366 (9492) :1189-1196
[6]
Adjuvant low-dose interferon α2a with or without dacarbazine compared with surgery alone:: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis [J].
Garbe, C. ;
Radny, P. ;
Linse, R. ;
Dummer, R. ;
Gutzmer, R. ;
Ulrich, J. ;
Stadler, R. ;
Weichenthal, M. ;
Eigentler, Tk. ;
Ellwanger, U. ;
Hauschild, A. .
ANNALS OF ONCOLOGY, 2008, 19 (06) :1195-1201
[7]
Diagnosis and treatment of cutaneous melanoma: state of the art 2006 [J].
Garbe, Claus ;
Elgentler, Thomas K. .
MELANOMA RESEARCH, 2007, 17 (02) :117-127
[8]
Prognostic significance of autoimmunity during treatment of melanoma with interferon [J].
Gogas, H ;
Ioannovich, J ;
Dafni, U ;
Stavropoulou-Giokas, C ;
Frangia, K ;
Tsoutsos, D ;
Panagiotou, P ;
Polyzos, A ;
Papadopoulos, O ;
Stratigos, A ;
Markopoulos, C ;
Bafaloukos, D ;
Pectasides, D ;
Fountzilas, G ;
Kirkwood, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (07) :709-718
[9]
Variations in management of stage I to stage III cutaneous melanoma - A population-based study of clinical practices in France [J].
Grange, Florent ;
Vitry, Fabien ;
Granel-Brocard, Florence ;
Lipsker, Dan ;
Aubin, Francois ;
Hedelin, Guy ;
Dalac, Sophie ;
Truchetet, Francois ;
Michel, Catherine ;
Batard, Marie-Laure ;
Baury, Beatrice ;
Halna, Jean-Michel ;
Schmutz, Jean Luc ;
Delvincourt, Christian ;
Reuter, Georges ;
Dalle, Stephane ;
Bernard, Phillipe ;
Danzon, Arlette .
ARCHIVES OF DERMATOLOGY, 2008, 144 (05) :629-636
[10]
Primary cutaneous diffuse large B-cell lymphoma, leg type - Clinicopathologic features and prognostic analysis in 60 cases [J].
Grange, Florent ;
Beylot-Barry, Marie ;
Courville, Phillipe ;
Maubec, Eve ;
Bagot, Martine ;
Vergier, Beatrice ;
Souteyrand, Pierre ;
Machet, Laurent ;
Dalac, Sophie ;
Esteve, Eric ;
Templier, Isabelle ;
Delaporte, Emmanuel ;
Avril, Marie-Francoise ;
Robert, Caroline ;
Dalle, Stephane ;
Laroche, Liliane ;
Delaunay, Michele ;
Joly, Pascal ;
Wechsler, Janine ;
Petrella, Tony .
ARCHIVES OF DERMATOLOGY, 2007, 143 (09) :1144-1150